• SENSEX
    NIFTY 50
Healthcare

Alembic Pharma gets USFDA's tentative approval for type 2 diabetes drug

Updated : August 27, 2020 01:07 PM IST

In a regulatory filing, Alembic Pharmaceuticals said it has received tentative approval from the US Food and Drug Administration (USFDA) for Empagliflozin and Linagliptin tablets in the strengths of 10 mg/5 mg and 25 mg/5 mg.
Alembic Pharma gets USFDA's tentative approval for type 2 diabetes drug

You May Also Like

Live TV

recommended for you

Advertisement